NO20082630L - Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse - Google Patents

Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse

Info

Publication number
NO20082630L
NO20082630L NO20082630A NO20082630A NO20082630L NO 20082630 L NO20082630 L NO 20082630L NO 20082630 A NO20082630 A NO 20082630A NO 20082630 A NO20082630 A NO 20082630A NO 20082630 L NO20082630 L NO 20082630L
Authority
NO
Norway
Prior art keywords
water
soluble
pharmaceutical compound
benzoazepine
compounds
Prior art date
Application number
NO20082630A
Other languages
English (en)
Other versions
NO342436B1 (no
Inventor
Makoto Komatsu
Fumitaka Goto
Yasuhiro Menjo
Keigo Yamada
Takakuni Matsuda
Yusuke Kato
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37877008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082630(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO20082630L publication Critical patent/NO20082630L/no
Publication of NO342436B1 publication Critical patent/NO342436B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C07F9/5535—Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en benzoazepinforbindelse representert ved følgende generelle formel (1): eller et salt derav, hvor R representerer et hydrogenatom, en hydroksygruppe eventuelt beskyttet med en beskyttelsesgruppe, etc., R1 representerer et hydrogenatom eller hydroksy-beskyttelsesgruppe og X representerer et oksygenatom eller et svovelatom. Benzoazepinforbindelse ifølge foreliggende oppfinnelse og salter derav har høy oppløselighet i vann og kan hensiktsmessig anvendes for injeksjoner.
NO20082630A 2005-12-27 2008-06-05 Vannoppløselig benzoazepinforbindelse, farmasøytisk preparat og vandig løsningspreparat derav NO342436B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005375457 2005-12-27
PCT/JP2006/326311 WO2007074915A1 (en) 2005-12-27 2006-12-22 Water-soluble benzoazepine compound and its pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO20082630L true NO20082630L (no) 2008-09-16
NO342436B1 NO342436B1 (no) 2018-05-22

Family

ID=37877008

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082630A NO342436B1 (no) 2005-12-27 2008-06-05 Vannoppløselig benzoazepinforbindelse, farmasøytisk preparat og vandig løsningspreparat derav

Country Status (22)

Country Link
US (6) US20100004206A1 (no)
EP (2) EP1968990B1 (no)
JP (2) JP4644287B2 (no)
KR (1) KR101008931B1 (no)
CN (1) CN101346390B (no)
AR (2) AR058737A1 (no)
AU (1) AU2006330277B2 (no)
BR (1) BRPI0620715A2 (no)
CA (1) CA2633929A1 (no)
CY (1) CY1116208T1 (no)
DK (1) DK1968990T3 (no)
ES (1) ES2533007T3 (no)
IL (1) IL191935A (no)
MY (1) MY146042A (no)
NO (1) NO342436B1 (no)
PL (1) PL1968990T3 (no)
PT (1) PT1968990E (no)
RU (1) RU2418804C2 (no)
SI (1) SI1968990T1 (no)
TW (1) TWI323257B (no)
WO (1) WO2007074915A1 (no)
ZA (1) ZA200805011B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459947B (zh) * 2007-06-26 2014-11-11 Otsuka Pharma Co Ltd 苯并氮呯化合物及藥學製劑
JP5590780B2 (ja) * 2007-06-26 2014-09-17 大塚製薬株式会社 医薬
WO2009149493A1 (en) * 2008-06-09 2009-12-17 Dimerix Bioscience Pty Ltd Novel receptor hetero-dimers/-oligomers
CN102020609A (zh) * 2009-09-17 2011-04-20 北京本草天源药物研究院 托伐普坦晶体或无定形物及其制备方法
DE102010041263A1 (de) * 2010-09-23 2012-03-29 Siemens Medical Instruments Pte. Ltd. Hörgerätegehäuse mit Dichtungslippe
TWI633887B (zh) 2012-05-31 2018-09-01 大塚製藥股份有限公司 用於預防及／或治療多囊性腎臟病之藥物
AR094291A1 (es) * 2012-12-28 2015-07-22 Otsuka Pharma Co Ltd Formulacion inyectable de liberacion prolongada que comprende tolvaptan opticamente activo, y un procedimiento para producirla
TW201605488A (zh) 2013-10-15 2016-02-16 大塚製藥股份有限公司 用以預防及／或治療多囊腎病之藥物
CN109476686B (zh) * 2016-07-07 2022-01-18 赛克里翁治疗有限公司 sGC刺激剂的磷前药
JP2021014406A (ja) * 2017-10-25 2021-02-12 トーアエイヨー株式会社 バソプレシン受容体拮抗剤
CN113383001A (zh) * 2019-01-30 2021-09-10 大塚制药株式会社 生产苯并氮杂卓化合物的方法
KR20210144810A (ko) * 2019-03-28 2021-11-30 오츠카 세이야쿠 가부시키가이샤 벤조아제핀 화합물-함유 동결건조 조성물
WO2020196816A1 (en) 2019-03-28 2020-10-01 Otsuka Pharmaceutical Co., Ltd. Benzoazepine compound-containing pharmaceutical composition
CN116744935A (zh) * 2021-02-10 2023-09-12 上海森辉医药有限公司 苯并氮杂䓬类化合物及其制备方法和医药用途
CN118593441A (zh) * 2024-06-07 2024-09-06 南京海纳医药科技股份有限公司 一种含有托伐普坦磷酸钠的冻干组合物及其制备方法
CN119684210A (zh) * 2024-12-09 2025-03-25 广东赛烽医药科技有限公司 托伐普坦磷酸钠化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043273A (en) 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
TW198715B (no) 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
DE19750002A1 (de) * 1997-11-12 1999-05-20 Solvay Pharm Gmbh Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5972882A (en) * 1997-12-15 1999-10-26 University Of Kansas Medical Center Treatment of polycystic kidney disease using vasopressin V2 receptor antagonists
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
TWI322689B (en) 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
EP1968990A1 (en) 2008-09-17
AU2006330277B2 (en) 2011-10-06
US20100004206A1 (en) 2010-01-07
US9809609B2 (en) 2017-11-07
ZA200805011B (en) 2009-11-25
CN101346390A (zh) 2009-01-14
NO342436B1 (no) 2018-05-22
US20120277188A1 (en) 2012-11-01
EP2674436A1 (en) 2013-12-18
RU2418804C2 (ru) 2011-05-20
US20110098250A1 (en) 2011-04-28
JP5550522B2 (ja) 2014-07-16
CY1116208T1 (el) 2017-02-08
US20110082110A1 (en) 2011-04-07
US20120277189A1 (en) 2012-11-01
CA2633929A1 (en) 2007-07-05
SI1968990T1 (sl) 2015-05-29
DK1968990T3 (da) 2015-04-27
TWI323257B (en) 2010-04-11
CN101346390B (zh) 2011-11-09
AR107193A2 (es) 2018-03-28
US20130331358A1 (en) 2013-12-12
AR058737A1 (es) 2008-02-20
JP2011046731A (ja) 2011-03-10
TW200734309A (en) 2007-09-16
MY146042A (en) 2012-06-15
WO2007074915A1 (en) 2007-07-05
RU2008130887A (ru) 2010-02-10
IL191935A0 (en) 2008-12-29
KR20080078916A (ko) 2008-08-28
PL1968990T3 (pl) 2015-06-30
JP2009521397A (ja) 2009-06-04
IL191935A (en) 2013-07-31
KR101008931B1 (ko) 2011-01-17
US9303052B2 (en) 2016-04-05
AU2006330277A1 (en) 2007-07-05
JP4644287B2 (ja) 2011-03-02
EP1968990B1 (en) 2015-02-11
WO2007074915A8 (en) 2007-11-08
ES2533007T3 (es) 2015-04-06
PT1968990E (pt) 2015-03-16
HK1121461A1 (en) 2009-04-24
BRPI0620715A2 (pt) 2011-11-22

Similar Documents

Publication Publication Date Title
NO20082630L (no) Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse
TW200616994A (en) Novel thiophene derivatives
UA99908C2 (ru) Пиридопиразиновые производные, способ борьбы с растениями, гербицидные композиции
UA102514C2 (ru) Производные иминопиридина, промежуточное соединение, способ борьбы с заражением полезных растений грибами или его предупреждение и композиция на основе производной иминопиридина
UA90209C2 (ru) Фунгицидная композиция, способ борьбы с заболеваниями полезных растений и способ защиты товаров
MY160542A (en) An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
NO20070445L (no) Pyrimidinderivater.
WO2008019395A3 (en) Compounds for improving learning and memory
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
PL1685142T3 (pl) Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
UA101018C2 (ru) Пирролопиримидинкарбоксамиды
MX2010001566A (es) Derivado de aminopirazolamida.
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20076000L (no) Aminosyrederivater
UA96149C2 (en) Method for producing 4-oxoquinoline compound
NO20076396L (no) Substituert akrylamidderivat og farmasoytisk preparat som omfatter dette
MX2009004558A (es) Compuesto amida o su sal, e inhibidor de formacion de biopelicula, quitador de biopelicula y bactericida usando cada uno el compuesto amida o su sal.
UA106628C2 (uk) Метилпіролопіримідинкарбоксаміди
CY1114378T1 (el) Μεθοδος χρησιμοποιησης συνδυασμου παραγωγου βενζοφαινονης ή αλατος αυτου και ανοσοκατασταλτικου παραγοντα, και φαρμακευτικη συνθεση που περιλαμβανει αυτα τα συστατικα
NO20060718L (no) Substituerte tiofoner og deres anvendelse
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
ATE554774T1 (de) 2-methylen-19-nor-(20s-24epi)-1alpha,25- dihydrovitamin-d2

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees